STRO vs UHS · rev $62.0M vs P/E 5.9, rev $15.83B
Sutro Biopharma (STRO) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported UHS revenue for 2024-12-31 was $15.83B. Net income was $1.16B. Revenue was up 10.8% from 2023-12-31 to 2024-12-31. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
STRO currently screens at market cap $470.8M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the STRO and UHS stock pages for the full models.
Not investment advice.